Generali Asset Management SPA SGR acquired a new stake in MetLife, Inc. (NYSE:MET - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 5,692 shares of the financial services provider's stock, valued at approximately $466,000.
A number of other large investors have also bought and sold shares of the business. Sierra Ocean LLC bought a new position in shares of MetLife during the 4th quarter worth approximately $32,000. Retirement Wealth Solutions LLC bought a new position in MetLife in the fourth quarter valued at $32,000. Values First Advisors Inc. acquired a new stake in MetLife in the 4th quarter valued at $36,000. Bank Julius Baer & Co. Ltd Zurich bought a new stake in MetLife during the 4th quarter worth about $48,000. Finally, Golden State Wealth Management LLC bought a new position in shares of MetLife in the 4th quarter valued at about $44,000. 94.99% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research firms recently issued reports on MET. Wells Fargo & Company upped their target price on MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a report on Wednesday, February 19th. JPMorgan Chase & Co. upped their price objective on MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 7th. Keefe, Bruyette & Woods decreased their target price on shares of MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a research note on Wednesday, February 12th. StockNews.com lowered shares of MetLife from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Finally, Barclays lowered their price objective on shares of MetLife from $96.00 to $95.00 and set an "overweight" rating on the stock in a research note on Friday, February 7th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $94.58.
View Our Latest Stock Analysis on MetLife
MetLife Stock Performance
MET stock traded down $0.48 during mid-day trading on Tuesday, hitting $83.70. 3,217,547 shares of the company were exchanged, compared to its average volume of 3,069,534. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The business has a 50 day simple moving average of $83.52 and a 200-day simple moving average of $82.73. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $57.02 billion, a PE ratio of 14.02, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04.
MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, equities analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were issued a dividend of $0.545 per share. The ex-dividend date of this dividend was Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.60%. MetLife's dividend payout ratio is presently 36.52%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.